{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:53:46Z","timestamp":1762005226261,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.bjid.2020.05.010","type":"journal-article","created":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T22:31:57Z","timestamp":1594506717000},"page":"310-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Activity of ceftolozane-tazobactam and comparators against gram-negative bacilli: Results from the study for monitoring antimicrobial resistance trends (SMART \u2013 Brazil; 2016\u20132017)"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2648-8767","authenticated-orcid":false,"given":"Elisa Maria","family":"Beir\u00e3o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suellen da Silva","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarik Klain de","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Brand\u00e3o","family":"Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina Della Negra de","family":"Paula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thales Jose Bueno","family":"Polis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Cristina","family":"Gales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2019","series-title":"Antibiotic Resistance Threats in the United States, 2019","author":"CDC","key":"10.1016\/j.bjid.2020.05.010_bib0005"},{"year":"2019","series-title":"Antibiotic Resistance Threats in the United States, 2019","author":"CDC","key":"10.1016\/j.bjid.2020.05.010_bib0010"},{"year":"2018","series-title":"Surveillance of antimicrobial resistance in Europe \u2013 Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2017","author":"European Centre for Disease Prevention and Control","key":"10.1016\/j.bjid.2020.05.010_bib0015"},{"key":"10.1016\/j.bjid.2020.05.010_bib0020","unstructured":"Boletim Seguran\u00e7a do Paciente e Qualidade em Servi\u00e7os de Sa\u00fade n\u00ba 17: Avalia\u00e7\u00e3o dos indicadores nacionais das infec\u00e7\u00f5es relacionadas \u00e0 assist\u00eancia \u00e0 sa\u00fade (IRAS) e resist\u00eancia microbiana do ano de 2017. Published on April 29th, 2019 https:\/\/app.powerbi.com\/view?r=eyJrIjoiZTFiOGRhOTYtYzZjOS00NmZmLWE5MWUtN2RkNDhiZGJiOGE1IiwidCI6ImI2N2FmMjNmLWMzZjMtNGQzNS04MGM3LWI3MDg1ZjVlZGQ4MSJ. Last accessed on September 23rd, 2019."},{"issue":"11","key":"10.1016\/j.bjid.2020.05.010_bib0025","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1128\/AAC.00296-11","article-title":"Carbapenems: past, present, and future","volume":"55","author":"Papp-Wallace","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"issue":"4","key":"10.1016\/j.bjid.2020.05.010_bib0030","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","article-title":"The global epidemiology of carbapenemase-producing Enterobacteriaceae","volume":"8","author":"Van Duin","year":"2017","journal-title":"Virulence."},{"year":"2019","series-title":"Performance Standards for Antimicrobial Susceptibility Testing: 29th Informational Supplement","author":"CLSI. M100Ed29E","key":"10.1016\/j.bjid.2020.05.010_bib0035"},{"key":"10.1016\/j.bjid.2020.05.010_bib0040","unstructured":"Brazilian Committee on Antimicrobial Susceptibility Testing \u2013 BrCAST. http:\/\/brcast.org.br\/documentos\/."},{"year":"2019","series-title":"Breakpoint tables for interpretation of MIC\u2019s and zone diameters, version 8.0, January 2019","author":"EUCAST","key":"10.1016\/j.bjid.2020.05.010_bib0045"},{"key":"10.1016\/j.bjid.2020.05.010_bib0050","unstructured":"Di\u00e1rio Oficial da Uni\u00e3o. PORTARIA N\u00ba 64, DE 11 DE DEZEMBRO DE 2018. Published on: December, 14th 2018 | Edition: 240 | Section: 1 | Page: 59. http:\/\/www.in.gov.br\/materia\/-\/asset_publisher\/Kujrw0TZC2Mb\/content\/id\/55217765\/do1-2018-12-14-portaria-n-64-de-11-de-dezembro-de-2018-55217696."},{"issue":"Suppl 1","key":"10.1016\/j.bjid.2020.05.010_bib0055","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1093\/ofid\/ofy345","article-title":"Antimicrobial Resistance Surveillance and New Drug Development","volume":"6","author":"Sader","year":"2019","journal-title":"Open Forum Infect Dis."},{"key":"10.1016\/j.bjid.2020.05.010_bib0060","unstructured":"Di\u00e1rio Oficial da Uni\u00e3o. RESOLU\u00c7\u00c3O-RE n\u00ba 45, de 4 de janeiro de 2018. Published on January, 1st 2019 08\/01\/2018, Edition: 5, Section: 1 \u2013 Supplement: Page: 10 http:\/\/www.in.gov.br\/materia\/-\/asset_publisher\/Kujrw0TZC2Mb\/content\/id\/25055718\/do1a-2018-01-08-resolucao-re-n-45-de-4-de-janeiro-de-2018-25055682."},{"issue":"4","key":"10.1016\/j.bjid.2020.05.010_bib0065","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02431-18","article-title":"Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the In Vitro Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa","volume":"63","author":"Yin","year":"2019","journal-title":"Antimicrob Agents Chemother."},{"issue":"3","key":"10.1016\/j.bjid.2020.05.010_bib0070","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/jac\/dky477","article-title":"Antimicrobial-resistant pathogens in Canadian ICUs: results of the CANWARD 2007 to 2016 study","volume":"74","author":"Denisuik","year":"2019","journal-title":"J Antimicrob Chemother."},{"issue":"12","key":"10.1016\/j.bjid.2020.05.010_bib0075","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01802-13","article-title":"Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa with various resistance patterns isolated in U.S. Hospitals (2011-2012)","volume":"57","author":"Farrell","year":"2013","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.bjid.2020.05.010_bib0080","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02125-17","article-title":"Activity of ceftolozane-tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae isolates collected from respiratory tract specimens of hospitalized patients in the United States during 2013 to 2015","volume":"62","author":"Castanheira","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.bjid.2020.05.010_bib0085","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/jac\/dkw374","article-title":"Efficacy of ceftolozane\/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials","volume":"72","author":"Popejoy","year":"2017","journal-title":"J Antimicrob Chemother."},{"issue":"9","key":"10.1016\/j.bjid.2020.05.010_bib0090","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00675-18","article-title":"In Vitro Activity of Ceftolozane-Tazobactam against Enterobacter cloacae Complex Clinical Isolates with Different \u03b2-Lactam Resistance Phenotypes","volume":"62","author":"Robin","year":"2018","journal-title":"Antimicrob Agents Chemother."},{"issue":"5","key":"10.1016\/j.bjid.2020.05.010_bib0095","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijantimicag.2016.07.021","article-title":"The differential importance of mutations within AmpD in cephalosporin resistance of Enterobacter aerogenes and Enterobacter cloacae","volume":"48","author":"Babouee Flury","year":"2016","journal-title":"Int J Antimicrob Agents."},{"issue":"8","key":"10.1016\/j.bjid.2020.05.010_bib0100","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/jac\/dkx136","article-title":"Activity of ceftolozane\/tazobactam against surveillance and\u2019 problem\u2019 Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles","volume":"72","author":"Livermore","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.bjid.2020.05.010_bib0105","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.bjid.2017.06.008","article-title":"Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013-2015)","volume":"21","author":"Pfaller","year":"2017","journal-title":"Braz J Infect Dis."},{"issue":"1","key":"10.1016\/j.bjid.2020.05.010_bib0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/infdis\/jix524","article-title":"An Analysis of the Epidemic of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Convergence of Two Evolutionary Mechanisms Creates the \"Perfect Storm\"","volume":"217","author":"Rojas","year":"2017","journal-title":"J Infect Dis."},{"issue":"1","key":"10.1016\/j.bjid.2020.05.010_bib0115","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1186\/s12879-016-2072-3","article-title":"Phenotypic and molecular detection of the bla KPC gene in clinical isolates from inpatients at hospitals in S\u00e3o Luis, MA","volume":"16","author":"Ribeiro","year":"2016","journal-title":"Brazil. BMC Infect Dis."},{"issue":"3","key":"10.1016\/j.bjid.2020.05.010_bib0120","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02125-17","article-title":"Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015","volume":"62","author":"Castanheira","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.bjid.2020.05.010_bib0125","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cid\/ciw243","article-title":"Ceftazidime\/Avibactam and Ceftolozane\/Tazobactam: Second-generation \u03b2-Lactam\/\u03b2-Lactamase Inhibitor Combinations","volume":"63","author":"van Duin","year":"2016","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.bjid.2020.05.010_bib0130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jgar.2018.08.021","article-title":"Draft genome sequence of KPC-2-producing Pseudomonas aeruginosa recovered from a bloodstream infection sample in Brazil","volume":"15","author":"de Oliveira Santos","year":"2018","journal-title":"J Glob Antimicrob Resist."},{"key":"10.1016\/j.bjid.2020.05.010_bib0135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jgar.2018.01.014","article-title":"Early detection of a hypervirulent KPC-2-producing Pseudomonas aeruginosa ST235 in Brazil","volume":"12","author":"de Paula-Petroli","year":"2018","journal-title":"J Glob Antimicrob Resist."},{"issue":"5","key":"10.1016\/j.bjid.2020.05.010_bib0140","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1128\/AAC.00247-16","article-title":"New Small Plasmid Harboring blaKPC-2 in Pseudomonas aeruginosa","volume":"60","author":"Galetti","year":"2016","journal-title":"Antimicrob Agents Chemother."},{"issue":"4","key":"10.1016\/j.bjid.2020.05.010_bib0145","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jgar.2015.07.002","article-title":"Emergence and spread of KPC-2-producing Pseudomonas aeruginosa isolates in a Brazilian teaching hospital","volume":"3","author":"Carrara-Marroni","year":"2015","journal-title":"J Glob Antimicrob Resist."},{"key":"10.1016\/j.bjid.2020.05.010_bib0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12941-014-0043-3","article-title":"Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance","volume":"13","author":"Rizek","year":"2014","journal-title":"Ann Clin Microbiol Antimicrob."},{"issue":"4","key":"10.1016\/j.bjid.2020.05.010_bib0155","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jac\/dkg416","article-title":"Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase","volume":"52","author":"Gales","year":"2003","journal-title":"J Antimicrob Chemother."},{"issue":"9","key":"10.1016\/j.bjid.2020.05.010_bib0160","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1590\/0074-02760160116","article-title":"Mechanisms of carbapenem resistance in endemic Pseudomonas aeruginosa isolates after an SPM-1 metallo-\u03b2-lactamase producing strain subsided in an intensive care unit of a teaching hospital in Brazil","volume":"111","author":"Cacci","year":"2016","journal-title":"Mem Inst Oswaldo Cruz."}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867020300891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867020300891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:55:29Z","timestamp":1761407729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867020300891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1413867020300891"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2020.05.010","relation":{},"ISSN":["1413-8670"],"issn-type":[{"type":"print","value":"1413-8670"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity of ceftolozane-tazobactam and comparators against gram-negative bacilli: Results from the study for monitoring antimicrobial resistance trends (SMART \u2013 Brazil; 2016\u20132017)","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2020.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedade Brasileira de Infectologia.","name":"copyright","label":"Copyright"}]}}